Skip to main content
All lobbying clients

ORCHARD THERAPEUTICS NORTH AMERICA

Lobbying client · Massachusetts · filed 2025 to 2026

Biopharmaceutical company.

$110,000 Reported spend
7 Filings counted
1 Firms hired
2 Bills named

Spend is reported income plus in-house expenses across 7 filings. Everything on this page is grouped by the client's LDA id (67047), not by name.

 Firms hired 1
 Bills named in these filings 2
  • HR 1509
    Accelerating Kids’ Access to Care Act of 2025
    5 filings
  • S 752
    Accelerating Kids’ Access to Care Act
    5 filings
 Reported by year 2 years
  • 2026 $50,000 2 filings
  • 2025 $60,000 5 filings
 Issues lobbied 1

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 3
  • HOUSE OF REPRESENTATIVES 5
  • SENATE 5
  • Health & Human Services, Dept of (HHS) 2
 Foreign entities disclosed 2
  • KYOWA KIRIN INTERNATIONAL PLC United Kingdom named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $20,000
  • ORCHARD THERAPEUTICS LIMITED United Kingdom named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem